Insiders · VOR

Robert Ang

President and CEO at Vor Biopharma Inc. (VOR)

Robert Ang has filed 29 insider reports with the SEC since February 2022, as president and CEO at Vor Biopharma Inc. (VOR). The latest filing, on August 11, 2025, is a Form 144 notice: Robert Ang plans to sell 18,382 VOR shares (~$36.4K).

Filings
29
Companies
1
Bought on market
None
Sold on market
None

Companies where Robert Ang is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Vor Biopharma Inc. logo
VOR
Vor Biopharma Inc.
President and CEO911,318$18.52Aug 11, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert Ang with

Other insiders at the same companies

Questions about Robert Ang

What is Robert Ang's role at Vor Biopharma Inc.?
Robert Ang reports to the SEC as president and CEO at Vor Biopharma Inc. (VOR), according to the latest filing on August 11, 2025.
How many shares does Robert Ang own?
After the latest filing that states it, Robert Ang directly owned 911,318 shares of Vor Biopharma Inc. (VOR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert Ang bought or sold stock recently?
No open-market purchases or sales by Robert Ang are on file. The filings report shares withheld for taxes or exercise price, grant or award and sale back to the company.
How do I get alerts when Robert Ang files?
Follow Robert Ang on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert Ang (SEC CIK 0001741283). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2022 on. View on SEC EDGAR · Get this as JSON